Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...
AbbVie has expanded the availability of SKYRIZI in Canada for ulcerative colitis, strengthening its presence in the ...
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
Epinephrine is the only proven anaphylaxis treatment to reduce the risk of hospitalization and death. However, only 21% of ...
Leqembi’s application now moves forward to the European Commission, which will issue a formal verdict for the injection that ...
February brought policy updates and several biosimilar approvals, including the first FDA approval for an insulin aspart biosimilar.
Right now, Rinvoq is approved in the European Union and the U.S. for the treatment of adults with radiographic axial ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended the approval of Vyjuvek for the ...
Approval would expand the use of Enhertu to breast cancer patients with nearly undetectable HER2 levels in their tumors.
The European Commission had requested the committee consider new data on the drug that became available after it had adopted its positive opinion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results